HBM Healthcare Investments announced the closing of a new equity investment of EUR 20 million in two tranches into the privately held and Switzerland based Amicus SA. The financing will allow Amicus to accelerate the growth of its pharmaceutical business in Central and Eastern Europe (CEE).
April 28, 2017 at 06:24PM
from Startupticker
No comments:
Post a Comment